# Clozapine-related Immunodeficiency in Parkinsons Disease

> **NCT06634641** · PHASE4 · RECRUITING · sponsor: **Centre Hospitalier Universitaire, Amiens** · enrollment: 24 (estimated)

## Conditions studied

- Clozapine
- Parkinson's Disease (PD)
- Immunodeficiency
- Psychosis

## Interventions

- **BIOLOGICAL:** blood test

## Key facts

- **NCT ID:** NCT06634641
- **Lead sponsor:** Centre Hospitalier Universitaire, Amiens
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-01
- **Primary completion:** 2027-09
- **Final completion:** 2027-09
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2025-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06634641

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06634641, "Clozapine-related Immunodeficiency in Parkinsons Disease". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT06634641. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*